Delivery Order FA500015D0013-FA500018FG028
Award Date 10/1/17
Potential Completion Date 9/30/18
Potential Value $84K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Elmendorf AFB, Anchorage, AK 99506, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order issued under a pre-existing indefinite delivery contract (IDC) to Immucor Inc., a manufacturer of in vitro diagnostic products and blood banking supplies. The $134,083.53 firm-fixed-price contract was awarded by the Pacific Air Forces, a component of the U.S. Air Force, for the provision of "DRUGS AND BIOLOGICALS" with no set-aside designation. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related consumables...
- This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
- This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
- This is a firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The $7,653.03 contract is for the provision of blood bank reagents and supplies under the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract does not have a set-aside designation. Immucor holds several significant Indefinite Delivery/Blanket Purchase...
- This is a delivery order contract awarded by the Department of the Air Force Air Education and Training Command to Immucor Inc., a for-profit manufacturer, for the lease of blood typing analyzers with reagents. The contract has a total potential value of $117,340.43 and a completion date of September 30, 2019. This award is not associated with a set-aside program. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation...
- This is a Delivery Order contract awarded to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and blood banking equipment. The contract was awarded by the Defense Health Agency (DHA) for $227,628.11 and has a period of performance ending on September 30, 2021. The contract is not designated as a set-aside. Immucor provides specialized reagents, blood analyzers, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood...
- This federal contract award to Immucor Inc., a for-profit manufacturer, is for the provision of reagents and an echo analyzer to support blood bank operations. The $784,855.51 firm fixed price purchase order was awarded on October 1, 2016 by the Medical Command division of the Department of Defense, with a period of performance through September 30, 2019. No set-aside designation was used. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood...
- This is a $91,866.32 firm fixed price delivery order contract awarded to Immucor Inc. by the Department of Defense's Bureau of Medicine and Surgery (BUMED). The contract is for the provision of blood reagents and is placed against Immucor's existing GSA Federal Supply Schedule (FSS) contract for in vitro diagnostics, reagents, and test kits. No set-aside was used for this award. Immucor is a leading provider of automated instrument-reagent systems, consumables, and services for blood transfusion...